EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cost‐Effectiveness of Universal Screen‐and‐Treat Strategies for Reducing Morbidity and Mortality of Chronic Hepatitis B in a High‐Endemicity City

Ngai Sze Wong, Denise Pui-Chung Chan, Grace Lai-Hung Wong iD, Shui Shan Lee

Journal of Viral Hepatitis · 2025

DOI: 10.1111/jvh.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2025. Verfasst von Ngai Sze Wong und 3 weiteren Autor:innen. Beteiligte Einrichtung: JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Hepatitis B, Chronic, Mass Screening. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the setting of high hepatitis B virus (HBV) endemicity, we studied the cost‐effectiveness of universal HBV screen‐and‐treat strategies for averting HBV‐related morbidity and mortality in Hong Kong, where diagnosis and treatment coverages are low. An age–sex‐specific compartmental model for 2000–2040 was developed, with the incorporation of population‐based screening strategies targeting different age groups. With a one‐time HBV screening programme in 2025–2029, 3.6%–8.9% of HBV‐related deaths could be averted. We evaluated the cost‐effectiveness of the screening strategies with primary‐care‐based management in different scenarios with components of annual drug cost levels, screening programme duration, starting year and targeted age groups. Incremental cost‐effectiveness ratio (ICER) was calculated, with the willingness‐to‐pay (WTP) threshold set at USD100,000/quality‐adjusted life years (QALY). At the standard drug cost level, only the screening strategy targeting the 40–49 years old is cost‐saving. When drug cost decreases to a low level, the strategy targeting the 35–49 years old (ICER USD97,042/QALY gained) is likely to be cost‐effective and screening 35–59 years old is marginally cost‐effective. In probabilistic sensitivity analysis, screening 40–49 years old (50%) and 35–59 years old (42%) have a half–half probability of being the most cost‐effective at USD100,000/QALY WTP threshold, but increased to 93% for screening 35–59 years old at USD150,000/QALY threshold. From scenario analysis, deferred initiation of screening and unlimited programme duration would increase the ICER. Universal HBV screening targeting individuals aged 35–59 years or 40–49 years in the general population, with an earlier start and limited duration of the programme, is likely to be cost‐effective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cost-Benefit AnalysisHepatitis B, ChronicMass ScreeningHumansAdultMiddle AgedMaleHong KongFemaleYoung AdultAgedAntiviral AgentsAdolescentQuality-Adjusted Life YearsChild

Stichwörter der Autor:innen

cost‐effectiveness analysishepatitis Bmass screeningmathematical model

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
  • Stanley Ho Centre for Emerging Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.
  • S.H. Ho Research Centre for Infectious Diseases, The Chinese University of Hong Kong, Hong Kong, China.
  • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.

ORCID-Profile: Grace Lai-Hung Wong

Zitieren

APA

Wong, N. S., Chan, D. P., Wong, G. L., & Lee, S. S. (2025). Cost‐Effectiveness of Universal Screen‐and‐Treat Strategies for Reducing Morbidity and Mortality of Chronic Hepatitis B in a High‐Endemicity City. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.70027

Vancouver

Wong NS, Chan DP, Wong GL, Lee SS. Cost‐Effectiveness of Universal Screen‐and‐Treat Strategies for Reducing Morbidity and Mortality of Chronic Hepatitis B in a High‐Endemicity City. Journal of Viral Hepatitis. 2025. doi:10.1111/jvh.70027

BibTeX
@article{Wong2025,
  author = {Wong, Ngai Sze and Chan, Denise Pui-Chung and Wong, Grace Lai-Hung and Lee, Shui Shan},
  title = {Cost‐Effectiveness of Universal Screen‐and‐Treat Strategies for Reducing Morbidity and Mortality of Chronic Hepatitis B in a High‐Endemicity City},
  journal = {Journal of Viral Hepatitis},
  year = {2025},
  doi = {10.1111/jvh.70027}
}
Kostenlos starten →